R&D Removing barriers in treatment-resistant depression pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.
Patients End-of-life choice means little without end-of-life support A strong end-of-life care system does not wait until the final days to step in.
Patients Will at-home treatments save the global healthcare industry? With global healthcare systems failing, it’s time to make patients active participants in their own health.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.